Europe South Asia Asia Pacific Americas Middle East Africa BBC Homepage World Service Education
BBC Homepagelow graphics version | feedback | help
BBC News Online
 You are in: Health
Front Page 
World 
UK 
UK Politics 
Business 
Sci/Tech 
Health 
Medical notes 
Background Briefings 
Education 
Sport 
Entertainment 
Talking Point 
In Depth 
AudioVideo 
Wednesday, 8 December, 1999, 02:43 GMT
Blood test for colorectal cancer
Microscope Cancer cells can be hard to spot


Doctors have developed a blood test for colorectal cancer that may, in the long-term, give patients a clearer idea of whether the disease is likely to spread, or return after surgery.

The test is designed to detect the spread of cancer from the intestine to the lymph nodes by searching for a protein in the blood.

Guanylyl cyclase C (GCC) is one of seven proteins made only by intestinal cells and colorectal cancer cells.

Chief researcher Dr Scott Waldman, director of clinical pharmacology at Thomas Jefferson University in Philadelphia, said: "This is a very, very sensitive and specific test to determine whether there is microscopic disease in the lymph nodes that would otherwise escape the eye of a pathologist."

Colorectal cancer, the third most common form of cancer, is a major killer.

In some cases, colorectal cancer can be cured by surgery alone.

Human error

But as many as 40 percent of patients initially thought cured by surgery see the disease return within three years.

The researchers studied 21 colorectal cancer patients divided into two groups, one of 11 patients who had been disease-free for at least six years, and the other of 10 patients in whom the cancer had returned within three years of surgery.

Researchers found no sign of GCC in lymph node samples from the first group, but the protein was present in every patient whose cancer had returned.

Doctors currently try to determine whether colorectal cancer has spread by removing lymph nodes and examining them under a microscope to look for cancer cells.

However, this is often subject to human error, as it can be difficult to spot cancer cells if there are less than five for every 100 normal cells.

The new test is sensitive enough to detect a single cancer cell among 10 million normal cells.

Five-year study

Detection of the spread of colorectal cancer is vital as doctors do not treat patients with chemotherapy unless they have evidence that there are cancer cells in the lymph nodes.

Larger scale clinical trials are needed before the test can be routinely used by doctors.

Dr Waldman plans to enroll between 1,000 and 2,000 patients in a large, prospective five-year study comparing the ability of the standard examination of lymph nodes to that of the GCC marker test to predict recurrent disease.

Dr Lesley Walker, head of science information at the Cancer Research Campaign, said a test that could highlight the spread of colorectal cancer to the lymph nodes could potentially be "very useful".

"Many patients with bowel cancer are diagnosed after the cancer has already spread," she said.

"If bowel cancer is truly restricted to the bowel then surgery equates to almost certain cure, but it is much more difficult to treat successfully once it has spread."

However, Dr Walker warned that a lot of research was needed to establish what level of protein in the blood indicated a problem.

She said levels of another protein, Carcinoembryonic Antigen (CEA) were already used to detect bowel cancer.

The research is published in Annals of Internal Medicine.

Search BBC News Online

Advanced search options
Launch console
BBC RADIO NEWS
BBC ONE TV NEWS
WORLD NEWS SUMMARY
PROGRAMMES GUIDE

See also:
02 Mar 99 |  Health
Early warning for second biggest cancer killer
19 Nov 99 |  Medical notes
Bowel cancer
15 Feb 99 |  Health
Huge variation in cancer survival rates
18 Nov 99 |  Health
Poor miss out on cancer treatment

Internet links:

The BBC is not responsible for the content of external internet sites
Links to other Health stories are at the foot of the page.


E-mail this story to a friend

Links to more Health stories